Spinal-Stim
Device Stimulator, Bone Growth, Non-Invasive
PDI 18257200079124
General payments
$469,397
Research payments
$1,452,682
Through program year 2025, $469,397 in general payments and $1,452,682 in research payments were reported against Spinal-Stim (Stimulator, Bone Growth, Non-Invasive).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $72,035 | 1,550 |
| 2024 | General | $139,219 | 1,202 |
| 2024 | Research | $86,816 | 2 |
| 2023 | General | $202,174 | 2,776 |
| 2023 | Research | $1,296,278 | 65 |
| 2022 | General | $31,270 | 819 |
| 2022 | Research | $66,012 | 8 |
| 2021 | General | $24,698 | 780 |
| 2021 | Research | $3,575 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,127 general · 78 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.